Similar articles

• Neoadjuvant chemotherapy in deeply invasive bladder cancer: the Italian experience. The Lombard Urologists.

  [No authors listed] [No authors listed] Semin Urol. 1990 Aug;8(3):205-9. Semin Urol. 1990. PMID: 2204982 Clinical Trial. No abstract available.
• Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.

  Simon SD, Srougi M. Simon SD, et al. Prog Clin Biol Res. 1990;353:169-74. Prog Clin Biol Res. 1990. PMID: 2217415 No abstract available.
• Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.

  Keating JP, Zincke H, Hahn RG, Morgan WR. Keating JP, et al. Prog Clin Biol Res. 1990;353:119-27. Prog Clin Biol Res. 1990. PMID: 2217409 No abstract available.
• Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.

  George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N. George L, et al. Urology. 2004 Sep;64(3):488-93. doi: 10.1016/j.urology.2004.04.088. Urology. 2004. PMID: 15351577 Review.
• Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.

  Koch MO, Coussens D. Koch MO, et al. Semin Urol. 1993 Feb;11(1):14-9. Semin Urol. 1993. PMID: 8465122 Review. No abstract available.